Connect with us

Health

Cancer drug pioneer praises RFK Jr., suggests link between childhood cancer and COVID shots

Published

5 minute read

From LifeSiteNews

By Calvin Freiburger

Trump nominee for Secretary of Health and Human Services Robert F. Kennedy Jr. received a ringing endorsement from an acclaimed medical expert on Tuesday who said the country needs to take seriously a possible link between the COVID-19 shots and childhood cancer.

Dr. Patrick Soon-Shiong is a billionaire who pioneered the cancer drug Abraxane and has owned and led multiple medical companies. In 2018, he purchased the Los Angeles Times (which he blocked from endorsing Democrat Kamala Harris for president in 2024), and his ImmunityBio was among the companies recruited by the Trump administration to contribute to Operation Warp Speed.

On Tuesday, Soon-Shiong appeared on the 2WAY podcast, where he shared his thoughts about some of the big medical policy questions of the next four years.

“I think people misunderstand Bobby Kennedy, Robert F. Kennedy. He’s really all about the science,” he said. “I’ve sat down with him, met with him for the first time. I’ve not known him until I sat down with him, because I wanted to understand what he was thinking. And after hours of sitting down with him, I was so impressed. He knows more about the science than most doctors.”

Soon-Shiong went on to say “we’re going to have to address the rising incidence of cancer. For the first time in my career, I’ve seen an 8-year-old, 9-year-old, 10-year-old with colon cancer. The first time in my career, I’ve had a 13-year-old child in our clinic die of metastatic pancreatic cancer. We have to face this effectiveness and reality.”

The doctor ended on an optimistic note, saying that “there are effective therapies because we understand the science in such an immense way,” and adding that he is “excited about this next four years of bringing this information across and not to scare the population to say, look, we could lead the world in our innovation and using healthcare as a foreign policy around the world.”

large body of evidence identifies significant risks to the COVID shots, which were developed and reviewed in a fraction of the time vaccines usually take under Operation Warp Speed.

The federal Vaccine Adverse Event Reporting System (VAERS) reports 38,264 deaths, 219,594 hospitalizations, 22,134 heart attacks, and 28,814 myocarditis and pericarditis cases as of December 27, among other ailments. CDC researchers have recognized a “high verification rate of reports of myocarditis to VAERS after mRNA-based COVID-19 vaccination,” leading to the conclusion that “under-reporting is more likely” than over-reporting.

An analysis of 99 million people across eight countries published in February in the journal Vaccine “observed significantly higher risks of myocarditis following the first, second and third doses” of mRNA-based COVID shots, as well as signs of increased risk of “pericarditis, Guillain-Barré syndrome, and cerebral venous sinus thrombosis,” and other “potential safety signals that require further investigation.” In April, the CDC was forced to release by court order 780,000 previously undisclosed reports of serious adverse reactions, and a study out of Japan found “statistically significant increases” in cancer deaths after third doses of mRNA-based COVID-19 injections and offered several theories for a causal link.

Earlier this month, a long-awaited Florida grand jury report on the COVID shot manufacturers found that there were “profound and serious issues” in pharmaceutical companies’ review process, including reluctance to share what evidence of adverse events they found.

All eyes are currently on Trump and his health team, which will be helmed by Kennedy at HHS. As one of the country’s most vocal critics of the COVID establishment and vaccines more generally, his nomination brought hope that the second Trump administration will take a critical reassessment of the shots that the returning president has previously embraced, although most of Kennedy’s comments since joining Trump have focused on other issues, such as conventional vaccines and harmful food additives.

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

Alberta

Alberta government’s plan will improve access to MRIs and CT scans

Published on

From the Fraser Institute

By Nadeem Esmail and Tegan Hill

The Smith government may soon allow Albertans to privately purchase diagnostic screening and testing services, prompting familiar cries from defenders of the status quo. But in reality, this change, which the government plans to propose in the legislature in the coming months, would simply give Albertans an option already available to patients in every other developed country with universal health care.

It’s important for Albertans and indeed all Canadians to understand the unique nature of our health-care system. In every one of the 30 other developed countries with universal health care, patients are free to seek care on their own terms with their own resources when the universal system is unwilling or unable to satisfy their needs. Whether to access care with shorter wait times and a more rapid return to full health, to access more personalized services or meet a personal health need, or to access new advances in medical technology. But not in Canada.

That prohibition has not served Albertans well. Despite being one of the highest-spending provinces in one of the most expensive universal health-care systems in the developed world, Albertans endure some of the longest wait times for health care and some of the worst availability of advanced diagnostic and medical technologies including MRI machines and CT scanners.

Introducing new medical technologies is a costly endeavour, which requires money and the actual equipment, but also the proficiency, knowledge and expertise to use it properly. By allowing Albertans to privately purchase diagnostic screening and testing services, the Smith government would encourage private providers to make these technologies available and develop the requisite knowledge.

Obviously, these new providers would improve access to these services for all Alberta patients—first for those willing to pay for them, and then for patients in the public system. In other words, adding providers to the health-care system expands the supply of these services, which will reduce wait times for everyone, not just those using private clinics. And relief can’t come soon enough. In Alberta, in 2024 the median wait time for a CT scan was 12 weeks and 24 weeks for an MRI.

Greater access and shorter wait times will also benefit Albertans concerned about their future health or preventative care. When these Albertans can quickly access a private provider, their appointments may lead to the early discovery of medical problems. Early detection can improve health outcomes and reduce the amount of public health-care resources these Albertans may ultimately use in the future. And that means more resources available for all other patients, to the benefit of all Albertans including those unable to access the private option.

Opponents of this approach argue that it’s a move towards two-tier health care, which will drain resources from the public system, or that this is “American-style” health care. But these arguments ignore that private alternatives benefit all patients in universal health-care systems in the rest of the developed world. For example, Switzerland, Germany, the Netherlands and Australia all have higher-performing universal systems that provide more timely care because of—not despite—the private options available to patients.

In reality, the Smith government’s plan to allow Albertans to privately purchase diagnostic screening and testing services is a small step in the right direction to reduce wait times and improve health-care access in the province. In fact, the proposal doesn’t go far enough—the government should allow Albertans to purchase physician appointments and surgeries privately, too. Hopefully the Smith government continues to reform the province’s health-care system, despite ill-informed objections, with all patients in mind.

Nadeem Esmail

Director, Health Policy, Fraser Institute

Tegan Hill

Director, Alberta Policy, Fraser Institute
Continue Reading

Health

RFK Jr’s argument for studying efficacy of various vaccines

Published on

From HHS Secretary Robert F Kennedy’s Facebook Page

To elevate America’s health, restore public trust, and reclaim our reputation for integrity and gold-standard science, President Donald J. Trump’s HHS will challenge even the most sacred public health dogmas through open debate and disciplined scientific scrutiny.

Continue Reading

Trending

X